Kumegawa, K., Yang, L., Miyata, K. and Maruyama, R. FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer-gene programs in basal-like breast cancer.
Front. Oncol., 13, 1156111 (2023) |
Tanaka, M., Homme, M., Teramura, Y., Kumegawa, K., Yamazaki, Y., Yamashita, K., Osato, M., Maruyama, R. and Nakamura, T. HEY::NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.
JCI insight, 8, e160279 (2023) |
Tanaka, M., Chuaychob, S., Homme, M., Yamazaki, Y., Lyu, R., Yamashita, K., Ae, K., Matsumoto, S., Kumegawa, K., Maruyama, R., Qu, W., Miyagi, Y., Yokokawa, R. and Nakamura, T. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
Nat. Commun., 14, 1957 (2023) |
Kamakura, N., Takahashi, M. and Jo, M. The toxicity of dysregulated Plk1 activity revealed by its suppressor mutations.
Genes Cells, in press (2023) |
Fujiwara, H., Nagayama, S., Kawachi, H., Nakano, K., Shimizu, Y., Katayama, R., Yao, R., Komai, Y., Hiyoshi, Y., Mukai, T., Yamaguchi, T., Nagasaki, T., Akiyoshi, T. and Fukunaga, Y. A Case of Laparoscopically Resected Rectal Neuroendocrine Carcinoma and Its Renal Metastasis with a Potential Sensitivity to Inhibitors of FGFR and the Bcl Family.
Journal of Surgery, 8, 1759 (2023) |
Takahashi, M., Okamoto, Y., Kato, Y., Shirahama, H., Tsukahara, S., Sugimoto, Y. and Tomida, A. Activating mutations in EGFR and PI3K promote ATF4 induction for NSCLC cell survival during amino acid deprivation.
Heliyon, in press (2023) |
Tanaka, M. and Nakamura, T. Targeting epigenetic aberrations of sarcoma in CRISPR era.
Genes Chromosomes Cancer, in press (2023) |
Yamashita, K., Baba, S., Togashi, Y., Dobashi, A., Ae, K., Matsumoto, S., Tanaka, M., Nakamura, T. and Takeuchi, K. Clinicopathologic and genetic characterization of angiofibroma of soft tissue: a study of 12 cases including two cases with AHRR::NCOA3 gene fusion.
Histopathology, in press (2023) |
Isoyama, S., Tamaki, N., Noguchi, Y., Okamura, M., Yoshimatsu, Y., Kondo, T., Suzuki, T., Yaguchi, S. and Dan, S. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.
Cell Death Dis., 14, 169 (2023) |
Saeki, S., Kumegawa, K., Takahashi, Y., Yang, L., Osako, T., Yasen, M., Otsuji, K., Miyata, K., Yamakawa, K., Suzuka, J., Sakimoto, Y., Ozaki, Y., Takano, T., Sano, T., Noda, T., Ohno, S., Yao, R., Ueno, T. and Maruyama, R. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Breast Cancer Res., 25, 21 (2023) |
